Efficacy of Glecaprevir/Pibrentasvir for Real-World HCV Infected Patients in the Northern Part of Tokyo, Japan

Hepatis virus C (HCV) infection causes liver cirrhosis and hepatocellular carcinoma (HCC) worldwide. The objective of our study was to examine the effects of the HCV nonstructural protein (NS) 3/4A inhibitor glecaprevir/NS5A inhibitor pibrentasvir on real-world HCV patients in the northern part of T...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamana, Yoichiro, Kanda, Tatsuo, Matsumoto, Naoki, Honda, Masayuki, Kumagawa, Mariko, Sasaki, Reina, Kanezawa, Shini, Mizutani, Taku, Yamagami, Hiroaki, Masuzaki, Ryota, Ishii, Tomotaka, Nirei, Kazushige, Moriyama, Mitsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658140/
https://www.ncbi.nlm.nih.gov/pubmed/34884231
http://dx.doi.org/10.3390/jcm10235529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658140/
https://www.ncbi.nlm.nih.gov/pubmed/34884231
http://dx.doi.org/10.3390/jcm10235529

Ejemplares similares